NGM Biopharmaceuticals, Inc.
NGM · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$28 | -$29 | -$38 | -$48 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | -$9 | -$1 | -$2 | $0 |
| Stock-Based Comp. | $6 | $6 | $7 | $9 |
| Change in WC | -$2 | -$4 | -$9 | -$3 |
| Other Non-Cash | $9 | $1 | $1 | -$0 |
| Operating Cash Flow | -$23 | -$27 | -$40 | -$42 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$1 |
| Net Acquisitions | $88 | -$27 | -$25 | -$36 |
| Inv. Purchases | -$34 | -$23 | -$35 | -$14 |
| Inv. Sales/Matur. | $61 | $50 | $59 | $51 |
| Other Inv. Act. | -$88 | $27 | $25 | $36 |
| Investing Cash Flow | $27 | $27 | $25 | $36 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $1 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1 | $0 |
| Financing Cash Flow | $0 | $0 | $1 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4 | -$0 | -$14 | -$6 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $54 | $57 | $72 | $77 |
| End Cash | $59 | $57 | $57 | $72 |
| Free Cash Flow | -$23 | -$27 | -$40 | -$42 |